title: [Intra-amniotic Rivanol injection for the mid-term interruption of pregnancy].
abstract: Authors report their experiences about the use of intraamniotic Rivanol injection in the interruption of midtrimester pregnancies. Instillation was made between 15-24 gestation weeks with the use of 0.1% Rivanol solution in 108 cases. The abortion occurred averagely 36.9 hours after induction without remarkable complications in all cases. According to their experiences the intraamniotic Rivanol injection is an effective and safe method for the interruption of second-trimester pregnancies.
authors.forename: S
authors.initials: S
authors.lastname: Gardó
authors.forename: M
authors.initials: M
authors.lastname: Nagy
mesh_terms: D000019:Abortifacient Agents / Q000008:administration & dosage; D000028:Abortion, Induced / Q000379:methods*; D000166:Acridines / Q000008:administration & dosage*; D000650:Amnion / Q000187:drug effects; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004975:Ethacridine / Q000008:administration & dosage* / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D011247:Pregnancy; D011262:Pregnancy Trimester, Second
chemical_list: D000019:Abortifacient Agents; D000166:Acridines; D004975:Ethacridine
vernacular_title: Intraamniális Rivanol feltöltés középidös terhességek megszakítására.